Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed (may or may not relate to the study), replaces the previous provenance wording, and the revision tag updated to v3.3.2.SummaryDifference0.1%

- Check15 days agoChange DetectedRemoved the government funding status notice, a site-wide banner about potential delays and operating status, which is not part of the study specifics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedThe screenshots show no changes to the core study content (title, eligibility criteria, interventions, outcomes); only minor layout adjustments and updated timestamps are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check58 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

- Check65 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check80 days agoChange DetectedUpdated to Revision v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.